|
The drug Byetta (exenatide) mimics the hormone GLP-1 (glucagonlike peptide-1). Byetta is made by Amylin Pharmaceuticals and is generally
prescribed for twice daily injection for type 2 diabetes.
In a recent study, Byetta achieved reduction in A1c levels of over 1% which is comparable to results observed with insulin therapy in combination with sulfonylurea and metformin.
To diabetics who must self-inject twice per day, a once daily dosing
schedule can be a huge benefit. Several drug companies are at work
on once daily insulin dosing schedules, so be on the lookout for
updates on this topic.
|